Synapse Loss and Microglial Activation Precede Tangles in a P301S Tauopathy Mouse Model

Yoshiyama, Yasumasa, Higuchi, Makoto, Zhang, Bin, Huang, Shu-Ming, Iwata, Nobuhisa, Saido, Takaomi C., Maeda, Jun, Suhara, Tetsuya +2 more·2007·Neuron

Cited by (1,029)

Items 301–400 of 1,029

  1. <i>In Vivo</i>Positron Emission Tomographic Imaging of Glial Responses to Amyloid-β and Tau Pathologies in Mouse Models of Alzheimer's Disease and Related Disorders
    Maeda, Jun, Zhang, Ming-Rong, Okauchi, Takashi, Ji, Bin, Ono, Maiko, Hattori, Satoko, Kumata, Katsushi, Iwata, Nobuhisa, Saido, Takaomi C., Trojanowski, John Q. et al. · 2011 · The Journal of Neuroscience
  2. Overview of Transgenic Mouse Models for Alzheimer's Disease
    Ariana Myers, Paul McGonigle · 2019 · Current Protocols in Neuroscience
  3. The six brain‐specific TAU isoforms and their role in Alzheimer's disease and related neurodegenerative dementia syndromes
    Sarah Buchholz, Hans Zempel · 2024 · Alzheimer s & Dementia
  4. Markers of neuroinflammation associated with Alzheimer’s disease pathology in older adults
    Popp, Julius, Oikonomidi, Aikaterini, Tautvydaitė, Domilė, Dayon, Loïc, Bacher, Michael, Migliavacca, Eugenia, Henry, Hugues, Kirkland, Richard, Severin, India, Wojcik, Jérôme et al. · 2017 · Brain, Behavior, and Immunity
  5. Abnormally phosphorylated tau is associated with neuronal and axonal loss in experimental autoimmune encephalomyelitis and multiple sclerosis
    Anderson, J. M., Hampton, D. W., Patani, R., Pryce, G., Crowther, R. A., Reynolds, R., Franklin, R. J. M., Giovannoni, G., Compston, D. A. S., Baker, D. et al. · 2008 · Brain
  6. X-linked ubiquitin-specific peptidase 11 increases tauopathy vulnerability in women
    Yan, Yan, Wang, Xinming, Chaput, Dale, Shin, Min-Kyoo, Koh, Yeojung, Gan, Li, Pieper, Andrew A., Woo, Jung-A.A., Kang, David E. · 2022 · Cell
  7. Understanding the Kinetic Roles of the Inducer Heparin and of Rod-like Protofibrils during Amyloid Fibril Formation by Tau Protein
    Gayathri Ramachandran, Jayant B. Udgaonkar · 2011 · Journal of Biological Chemistry
  8. Transcription factor NRF2 as a promising therapeutic target for Alzheimer’s disease
    Zhuo Qu, Jiachen Sun, Wannian Zhang, Jian‐Qiang Yu, Chunlin Zhuang · 2020 · Free Radical Biology and Medicine
  9. In vivo tau PET imaging in dementia: Pathophysiology, radiotracer quantification, and a systematic review of clinical findings
    Hall, Benjamin, Mak, Elijah, Cervenka, Simon, Aigbirhio, Franklin I., Rowe, James B., O’Brien, John T. · 2017 · Ageing Research Reviews
  10. Formation and Propagation of Tau Oligomeric Seeds
    Julia E. Gerson, Rakez Kayed · 2013 · Frontiers in Neurology
  11. Interleukin-1β-dependent Signaling between Astrocytes and Neurons Depends Critically on Astrocytic Calcineurin/NFAT Activity
    Michelle A. Sama, Diana M. Mathis, Jennifer L. Furman, Hafiz Mohmmad Abdul, Irina A. Artiushin, Susan D. Kraner, Christopher Mark Norris · 2008 · Journal of Biological Chemistry
  12. Parkin Ubiquitinates Tar-DNA Binding Protein-43 (TDP-43) and Promotes Its Cytosolic Accumulation via Interaction with Histone Deacetylase 6 (HDAC6)
    Michaeline L. Hebron, Irina Lonskaya, Kaydee Sharpe, Puwakdandawe P.K. Weerasinghe, Norah Khaled Algarzae, Ashot R. Shekoyan, Charbel Moussa · 2012 · Journal of Biological Chemistry
  13. Endoplasmic Reticulum Stress Induces Tau Pathology and Forms a Vicious Cycle: Implication in Alzheimer's Disease Pathogenesis
    Janice Yuen Shan Ho, Xifei Yang, Jeffery Chi-Fai Lau, Clara Hiu-Ling Hung, Suthicha Wuwongse, Qishan Zhang, Jian‐Zhi Wang, Larry Baum, Kwok‐Fai So, Raymond Chuen‐Chung Chang · 2012 · Journal of Alzheimer s Disease
  14. Behavioral deficit, oxidative stress, and mitochondrial dysfunction precede tau pathology in P301S transgenic mice
    Magali Dumont, Cliona Stack, Ceyhan Elipenahli, Shari Jainuddin, Meri Gerges, Natalia N. Starkova, Lichuan Yang, Anatoly A. Starkov, Flint M. Beal · 2011 · The FASEB Journal
  15. Removing endogenous tau does not prevent tau propagation yet reduces its neurotoxicity
    Wegmann, Susanne, Maury, Eduardo A, Kirk, Molly J, Saqran, Lubna, Roe, Allyson, DeVos, Sarah L, Nicholls, Samantha, Fan, Zhanyun, Takeda, Shuko, Cagsal‐Getkin, Ozge et al. · 2015 · The EMBO Journal
  16. Noninvasive 40-hz light flicker to recruit microglia and reduce amyloid beta load
    Singer, Annabelle C., Martorell, Anthony J., Douglas, J. Miller, Abdurrob, Fatema, Attokaren, Matthew K., Tipton, John, Mathys, Hansruedi, Adaikkan, Chinnakkaruppan, Tsai, Li-Huei · 2018 · Nature Protocols
  17. Microglial derived tumor necrosis factor-α drives Alzheimer's disease-related neuronal cell cycle events
    Kiran Bhaskar, Nicole M. Maphis, Guixiang Xu, Nicholas H. Varvel, Olga N. Kokiko‐Cochran, Jason Porter Weick, Susan M. Staugaitis, Astrid E. Cardona, Richard M. Ransohoff, Karl Herrup et al. · 2013 · Neurobiology of Disease
  18. Preventive methylene blue treatment preserves cognition in mice expressing full-length pro-aggregant human Tau
    Katja Hochgräfe, Astrid Sydow, Dorthe Matenia, Daniela Cadinu, Stefanie Könen, Olga M. Petrova, Marcus Pickhardt, Petra Goll, Fabio Morellini, Eckhard Mandelkow� et al. · 2015 · Acta Neuropathologica Communications
  19. Intracellular Calcium Dysregulation: Implications for Alzheimer’s Disease
    Simona Magi, Pasqualina Castaldo, Maria Loredana Macrì, Marta Maiolino, Alessandra Matteucci, Guendalina Bastioli, Santo Gratteri, Salvatore Amoroso, Vincenzo Lariccia · 2016 · BioMed Research International
  20. Functional and structural damage of neurons by innate immune mechanisms during neurodegeneration
    Christina Ising, Michael Thomas Heneka · 2018 · Cell Death and Disease
  21. Dendritic Pathology in Prion Disease Starts at the Synaptic Spine
    Martin Fuhrmann, Gerda Mitteregger, Hans A. Kretzschmar, Jochen Wolfgang Herms · 2007 · Journal of Neuroscience
  22. The Role of Neuroinflammation in Dementias
    Pasqualetti, Giuseppe, Brooks, David J., Edison, Paul · 2015 · Current Neurology and Neuroscience Reports
  23. Early Reduction of Microglia Activation by Irradiation in a Model of Chronic Glaucoma
    Alejandra Bosco, Samuel D. Crish, Michael R. Steele, Cesar O. Romero, Denise M. Inman, Philip J. Horner, David John Calkins, Monica L. Vetter · 2012 · PLoS ONE
  24. Locus Coeruleus Ablation Exacerbates Cognitive Deficits, Neuropathology, and Lethality in P301S Tau Transgenic Mice
    Chalermpalanupap, Termpanit, Schroeder, Jason P., Rorabaugh, Jacki M., Liles, L. Cameron, Lah, James J., Levey, Allan I., Weinshenker, David · 2018 · The Journal of Neuroscience
  25. Early axonopathy preceding neurofibrillary tangles in mutant tau transgenic mice
    Leroy, Karelle, Bretteville, Alexis, Schindowski, Katharina, Gilissen, Emmanuel, Authelet, Michèle, De Decker, Robert, Yilmaz, Zehra, Buée, Luc, Brion, Jean-Pierre · 2007 · The American Journal of Pathology
  26. Persistent activation of microglia is associated with neuronal dysfunction of callosal projecting pathways and multiple sclerosis-like lesions in relapsing–remitting experimental autoimmune encephalomyelitis
    Rasmussen, Stine, Wang, Yue, Kivisäkk, Pia, Bronson, Roderick T., Meyer, Morten, Imitola, Jaime, Khoury, Samia J. · 2007 · Brain
  27. Cognitive defects are reversible in inducible mice expressing pro-aggregant full-length human Tau
    Van der Jeugd, Ann, Hochgräfe, Katja, Ahmed, Tariq, Decker, Jochen M., Sydow, Astrid, Hofmann, Anne, Wu, Dan, Messing, Lars, Balschun, Detlef, D’Hooge, Rudi et al. · 2012 · Acta Neuropathologica
  28. Linking Oxidative Stress and Proteinopathy in Alzheimer’s Disease
    Chanchal Sharma, Sang Ryong Kim · 2021 · Antioxidants
  29. Inflammatory aspects of Alzheimer’s disease
    Pablo Botella Lucena, Michael Thomas Heneka · 2024 · Acta Neuropathologica
  30. Neuronal APOE4 removal protects against tau-mediated gliosis, neurodegeneration and myelin deficits
    Koutsodendris, Nicole, Blumenfeld, Jessica, Agrawal, Ayushi, Traglia, Michela, Grone, Brian, Zilberter, Misha, Yip, Oscar, Rao, Antara, Nelson, Maxine R., Hao, Yanxia et al. · 2023 · Nature Aging
  31. In-vivo imaging of grey and white matter neuroinflammation in Alzheimer’s disease: a positron emission tomography study with a novel radioligand, [18F]-FEPPA
    Suridjan, I, Pollock, B G, Verhoeff, N P L G, Voineskos, A N, Chow, T, Rusjan, P M, Lobaugh, N J, Houle, S, Mulsant, B H, Mizrahi, R · 2015 · Molecular Psychiatry
  32. Microglial Malfunction: The Third Rail in the Development of Alzheimer's Disease
    Mhatre, Siddhita D., Tsai, Connie A., Rubin, Amanda J., James, Michelle L., Andreasson, Katrin I. · 2015 · Trends in Neurosciences
  33. Molecular and cellular mechanisms of selective vulnerability in neurodegenerative diseases
    Martin Kampmann · 2024 · Nature reviews. Neuroscience
  34. The Role of Microglia in Synaptic Stripping and Synaptic Degeneration: A Revised Perspective
    Victor Hugh Perry, Vincent M. O'Connor · 2010 · ASN NEURO
  35. Efficacy of small‐molecule glycogen synthase kinase‐3 inhibitors in the postnatal rat model of tau hyperphosphorylation
    M. L. Selenica, H S Jensen, Anna Kirstine Larsen, Mette Lund Pedersen, Lone Helboe, Marcel Leist, Julie Lotharius · 2007 · British Journal of Pharmacology
  36. Insulin dysfunction and Tau pathology
    Noura B. El Khoury, Maud Gratuze, Marie-Amélie Papon, Alexis Bretteville, Emmanuel Planel · 2014 · Frontiers in Cellular Neuroscience
  37. Therapeutic strategies for tau mediated neurodegeneration
    Yasumasa Yoshiyama, Virginia M.‐Y. Lee, John Q. Trojanowski · 2012 · Journal of Neurology Neurosurgery & Psychiatry
  38. Expression of A152T human tau causes age‐dependent neuronal dysfunction and loss in transgenic mice
    Sumihiro Maeda, Biljana Djukic, Praveen Taneja, Gui-Qiu Yu, Iris Lo, Allyson Davis, Ryan Craft, Weikun Guo, Xin Wang, Daniel Kim et al. · 2016 · EMBO Reports
  39. Neuronal DNA double-strand breaks lead to genome structural variations and 3D genome disruption in neurodegeneration
    Dileep, Vishnu, Boix, Carles A., Mathys, Hansruedi, Marco, Asaf, Welch, Gwyneth M., Meharena, Hiruy S., Loon, Anjanet, Jeloka, Ritika, Peng, Zhuyu, Bennett, David A. et al. · 2023 · Cell
  40. Emerging Roles of Astrocytes in Neuro-Vascular Unit and the Tripartite Synapse With Emphasis on Reactive Gliosis in the Context of Alzheimer’s Disease
    Liu, Cai-Yun, Yang, Yu, Ju, Wei-Na, Wang, Xu, Zhang, Hong-Liang · 2018 · Frontiers in Cellular Neuroscience
  41. Mitochondrial dysfunctions, oxidative stress and neuroinflammation as therapeutic targets for neurodegenerative diseases: An update on current advances and impediments
    Rehman, Muneeb U., Sehar, Nouroz, Dar, Nawab John, Khan, Andleeb, Arafah, Azher, Rashid, Summya, Rashid, Shahzada Mudasir, Ganaie, Majid Ahmad · 2023 · Neuroscience &amp; Biobehavioral Reviews
  42. Minocycline reduces the development of abnormal tau species in models of Alzheimer's disease
    W. Noble, C. Garwood, J. Stephenson, Anna M. Kinsey, D. Hanger, B. Anderton · 2009 · The FASEB Journal
  43. Transgenic Mouse Models of Alzheimer’s Disease: An Integrative Analysis
    Raquel Maria Sanchez-Varo, Marina Mejias‐Ortega, Juan José Fernandez-Valenzuela, Cristina Nuñez‐Diaz, Laura Cáceres-Palomo, Laura Vegas‐Gomez, Elisabeth Sánchez‐Mejías, Laura Trujillo‐Estrada, Juan Antonio García‐León, Inés Moreno‐González et al. · 2022 · International Journal of Molecular Sciences
  44. Microglial-to-neuronal CCR5 signaling regulates autophagy in neurodegeneration
    Festa, Beatrice Paola, Siddiqi, Farah H., Jimenez-Sanchez, Maria, Won, Hyeran, Rob, Matea, Djajadikerta, Alvin, Stamatakou, Eleanna, Rubinsztein, David C. · 2023 · Neuron
  45. Involvement of inflammation in Alzheimer’s disease pathogenesis and therapeutic potential of anti-inflammatory agents
    Sina Shadfar, Chul Ju Hwang, Mi‐sun Lim, Dong‐Young Choi, Jin Tae Hong · 2015 · Archives of Pharmacal Research
  46. Interaction between pathogenic proteins in neurodegenerative disorders
    K. A. Jellinger · 2011 · Journal of Cellular and Molecular Medicine
  47. Phagocytosis of full-length Tau oligomers by Actin-remodeling of activated microglia
    Rashmi Ranjan Das, Abhishek Ankur Balmik, Subashchandrabose Chinnathambi · 2020 · Journal of Neuroinflammation
  48. Psychosocial stress on neuroinflammation and cognitive dysfunctions in Alzheimer's disease: the emerging role for microglia?
    Sami Piirainen, Andrew M. Youssef, Cai Song, Allan V. Kalueff, Gary E. Landreth, Tarja Malm, Li Tian · 2017 · Neuroscience & Biobehavioral Reviews
  49. Crucial role of protein oligomerization in the pathogenesis of Alzheimer's and Parkinson's diseases
    Minee L. Choi, Sonia Gandhi · 2018 · FEBS Journal
  50. Synaptic Loss in Alzheimer's Disease: Mechanistic Insights Provided by Two-Photon in vivo Imaging of Transgenic Mouse Models
    Jaichandar Subramanian, Julie C. Savage, Marie‐Ève Tremblay · 2020 · Frontiers in Cellular Neuroscience
  51. Microglia in Aging and Alzheimer’s Disease: A Comparative Species Review
    Edler, Melissa K., Mhatre-Winters, Isha, Richardson, Jason R. · 2021 · Cells
  52. Toxic tau oligomer formation blocked by capping of cysteine residues with 1,2-dihydroxybenzene groups
    Yoshiyuki Soeda, Misato Yoshikawa, Osborne F. X. Almeida, Akio Sumioka, Sumihiro Maeda, Hiroyuki Osada, Yasumitsu Kondoh, Akiko Saito, Tomohiro Miyasaka, Tetsuya Kimura et al. · 2015 · Nature Communications
  53. Selectively silencing GSK-3 isoforms reduces plaques and tangles in mouse models of Alzheimer's disease
    Hurtado, David E., Molina-Porcel, Laura, Carroll, Jenna C., MacDonald, Caryn, Aboagye, Awo K., Trojanowski, John Q., Lee, Virginia M.-Y. · 2012 · The Journal of Neuroscience
  54. Synaptic alterations in the rTg4510 mouse model of tauopathy
    Katherine J. Kopeikina, Manuela Polydoro, Hwan‐Ching Tai, Erich Yaeger, George A. Carlson, Rose Pitstick, Bradley T. Hyman, Tara L. Spires‐Jones · 2012 · The Journal of Comparative Neurology
  55. Evidence that Non-Fibrillar Tau Causes Pathology Linked to Neurodegeneration and Behavioral Impairments
    Kurt R. Brunden, John Q. Trojanowski, Virginia M.‐Y. Lee · 2008 · Journal of Alzheimer s Disease
  56. Neuroinflammation and protein aggregation co-localize across the frontotemporal dementia spectrum
    Bevan-Jones, W Richard, Cope, Thomas E, Jones, P Simon, Kaalund, Sanne S, Passamonti, Luca, Allinson, Kieren, Green, Oliver, Hong, Young T, Fryer, Tim D, Arnold, Robert et al. · 2020 · Brain
  57. Tau induces PSD95–neuronal NOS uncoupling and neurovascular dysfunction independent of neurodegeneration
    Laibaik Park, Karin Hochrainer, Yorito Hattori, Sung Ji Ahn, Antoine Anfray, Gang Wang, Ken Uekawa, James Seo, Victoria L. Palfini, Ismary Blanco et al. · 2020 · Nature Neuroscience
  58. Microglia in Alzheimer’s Disease in the Context of Tau Pathology
    Juan Ramón Perea, Marta Bolós, Jesús Ávila · 2020 · Biomolecules
  59. Microglial priming in Alzheimer’s disease
    Li, Jun-Wei, Zong, Yu, Cao, Xi-Peng, Tan, Lin, Tan, Lan · 2018 · Annals of Translational Medicine
  60. The behavioural and neuropathologic sexual dimorphism and absence of MIP-3α in tau P301S mouse model of Alzheimer’s disease
    Sun, Yao, Guo, Yongqing, Feng, Xuejian, Jia, Meng, Ai, Ning, Dong, Yue, Zheng, Yayuan, Fu, Lu, Yu, Bin, Zhang, Haihong et al. · 2020 · Journal of Neuroinflammation
  61. Modulation of inflammation in transgenic models of Alzheimer’s disease
    Amy M. Birch, Loukia Katsouri, Magdalena Sastre · 2014 · Journal of Neuroinflammation
  62. 25-Hydroxycholesterol amplifies microglial IL-1β production in an apoE isoform-dependent manner
    Wong, Man Ying, Lewis, Michael, Doherty, James J., Shi, Yang, Cashikar, Anil G., Amelianchik, Anna, Tymchuk, Svitlana, Sullivan, Patrick M., Qian, Mingxing, Covey, Douglas F. et al. · 2020 · Journal of Neuroinflammation
  63. Systems-based proteomics to resolve the biology of Alzheimer’s disease beyond amyloid and tau
    Rayaprolu, Sruti, Higginbotham, Lenora, Bagchi, Pritha, Watson, Caroline M., Zhang, Tian, Levey, Allan I., Rangaraju, Srikant, Seyfried, Nicholas T. · 2021 · Neuropsychopharmacology
  64. Temsirolimus attenuates tauopathy in vitro and in vivo by targeting tau hyperphosphorylation and autophagic clearance
    Teng Jiang, Jin‐Tai Yu, Xi‐Chen Zhu, Qiao-Quan Zhang, Lei Cao, Hui-Fu Wang, Meng‐Shan Tan, Qing Gao, Hao Qin, Yingdong Zhang et al. · 2014 · Neuropharmacology
  65. The emerging role of peptidyl‐prolyl isomerase chaperones in tau oligomerization, amyloid processing, and Alzheimer's disease
    Laura J. Blair, Jeremy D. Baker, Jonathan J. Sabbagh, Chad A. Dickey · 2015 · Journal of Neurochemistry
  66. AMP-activated protein kinase modulates tau phosphorylation and tau pathology in vivo
    Manon Domise, Sébastien Didier, Claudia Marinangeli, Haitian Zhao, Pallavi Chandakkar, Luc Buée, Benoı̂t Viollet, Peter Davies, Philippe Marambaud, Valérie Vingtdeux · 2016 · Scientific Reports
  67. Therapeutic Strategies for Alzheimer’s Disease
    Donna M. Barten, Charles F. Albright · 2008 · Molecular Neurobiology
  68. Knock-out and transgenic mouse models of tauopathies
    Franziska Denk, Richard Wade‐Martins · 2007 · Neurobiology of Aging
  69. A comprehensive resource for induced pluripotent stem cells from patients with primary tauopathies
    Karch, Celeste M., Kao, Aimee W., Karydas, Anna, Onanuga, Khadijah, Martinez, Rita, Argouarch, Andrea, Wang, Chao, Huang, Cindy, Sohn, Peter Dongmin, Bowles, Kathryn R. et al. · 2019 · Stem Cell Reports
  70. The APOE-R136S mutation protects against APOE4-driven tau pathology, neurodegeneration, and neuroinflammation
    Nelson, Maxine R., Liu, Peng, Agrawal, Ayushi, Yip, Oscar, Blumenfeld, Jessica, Traglia, Michela, Kim, Min Joo, Koutsodendris, Nicole, Rao, Antara, Grone, Brian et al. · 2023 · Nature Neuroscience
  71. Microglial P2X7receptor expression is accompanied by neuronal damage in the cerebral cortex of the APPswe/PS1dE9 mouse model of Alzheimer's disease
    Hwan Goo Lee, Sun Mi Won, Byoung Joo Gwag, Yong Beom Lee · 2011 · Experimental & Molecular Medicine
  72. New perspectives on the role of tau in Alzheimer's disease. Implications for therapy
    Miguel Medina, Jesús Ávila · 2014 · Biochemical Pharmacology
  73. Tau interactome mapping based identification of Otub1 as Tau deubiquitinase involved in accumulation of pathological Tau forms in vitro and in vivo
    Peng Wang, Gérard Joberty, Arjan Buist, Alexandre Vanoosthuyse, Ilie‐Cosmin Stancu, Bruno Vasconcelos, Nathalie Pierrot, Maria Faelth-Savitski, Pascal Kienlen‐Campard, Jean‐Noël Octave et al. · 2017 · Acta Neuropathologica
  74. Reduced gliotransmitter release from astrocytes mediates tau‐induced synaptic dysfunction in cultured hippocampal neurons
    Roberto Piacentini, Domenica Donatella Li Puma, Marco Mainardi, Giacomo Lazzarino, Barbara Tavazzi, Ottavio Arancio, Claudio Grassi · 2017 · Glia
  75. Neuroinflammation in mouse models of Alzheimer's disease
    Takashi Saito, Takaomi C. Saido · 2018 · Clinical and Experimental Neuroimmunology
  76. Synapses and Dendritic Spines as Pathogenic Targets in Alzheimer’s Disease
    Wendou Yu, Bingwei Lu · 2012 · Neural Plasticity
  77. Tumour Necrosis Factor Modulation for Treatment of Alzheimerʼs Disease: Rationale and Current Evidence
    Tobinick, Edward · 2009 · CNS Drugs
  78. Silencing of TREM2 exacerbates tau pathology, neurodegenerative changes, and spatial learning deficits in P301S tau transgenic mice
    Jiang, Teng, Tan, Lan, Zhu, Xi-Chen, Zhou, Jun-Shan, Cao, Lei, Tan, Meng-Shan, Wang, Hui-Fu, Chen, Qi, Zhang, Ying-Dong, Yu, Jin-Tai · 2015 · Neurobiology of Aging
  79. Immunotherapy Targeting Pathological Tau Protein in Alzheimer's Disease and Related Tauopathies
    Sigurdsson, Einar M. · 2008 · Journal of Alzheimer's Disease
  80. Phosphorylation of Tau at S422 is enhanced by Aβ in TauPS2APP triple transgenic mice
    Grueninger, Fiona, Bohrmann, Bernd, Czech, Christian, Ballard, Theresa Maria, Frey, Johann R., Weidensteiner, Claudia, von Kienlin, Markus, Ozmen, Laurence · 2010 · Neurobiology of Disease
  81. Vulnerability and resilience to Alzheimer’s disease: early life conditions modulate neuropathology and determine cognitive reserve
    Sylvie L. Lesuis, Lianne Hoeijmakers, Anikó Kőrösi, Susanne R. de Rooij, Dick Frans Swaab, Helmut W. H. G. Kessels, Paul John Lucassen, Harm J. Krugers · 2018 · Alzheimer s Research & Therapy
  82. Modulating TRADD to restore cellular homeostasis and inhibit apoptosis
    Daichao Xu, Heng Zhao, Minzhi Jin, Hong Zhu, Bing Shan, Jiefei Geng, Slawomir A. Dziedzic, Palak P. Amin, Lauren Mifflin, Masanori Gomi Naito et al. · 2020 · Nature
  83. In vivo molecular imaging of neuroinflammation in Alzheimer's disease
    Aisling M. Chaney, S. R. Williams, Hervé Boutin · 2018 · Journal of Neurochemistry
  84. Synaptic Elimination in Neurological Disorders
    Pablo Leal Cardozo, Izabella B. Q. de Lima, Esther M. A. Maciel, Nathália C. Silva, Tomáš Dobránsky, Fabiola Mara Ribeiro · 2019 · Current Neuropharmacology
  85. Changes in visual function and retinal structure in the progression of Alzheimer's disease
    Elena Salobrar‐García, Rosa de Hoz, Ana Isabel Ramirez, Inés López‐Cuenca, Pilar Rojas, Ravi Vazirani, Carla Amarante Cuadrado, Raquel Yubero, Pedro Gil, Maria Dolores Pinazo-Duran et al. · 2019 · PLoS ONE
  86. Tau Ser208 phosphorylation promotes aggregation and reveals neuropathologic diversity in Alzheimer’s disease and other tauopathies
    Yuxing Xia, Stefan Prokop, Kimberly-Marie M. Gorion, Justin D. Kim, Zachary A. Sorrentino, Brach M. Bell, Alyssa N. Manaois, Paramita Chakrabarty, Peter Davies, Benoit I. Giasson · 2020 · Acta Neuropathologica Communications
  87. Synaptic tau: A pathological or physiological phenomenon?
    Miranda Robbins, Emma L. Clayton, Gabriele S. Kaminski Schierle · 2021 · Acta Neuropathologica Communications
  88. Pin1 has opposite effects on wild-type and P301L tau stability and tauopathy
    Jormay Lim, Martin Balaštík, Tae Ho Lee, Kazuhiro Nakamura, Yih‐Cherng Liou, Anyang Sun, Greg Finn, Lucia Pastorino, Virginia M.‐Y. Lee, Kun Ping Lu · 2008 · Journal of Clinical Investigation
  89. Altered sleep and EEG power in the P301S Tau transgenic mouse model
    Jerrah K. Holth, Thomas E. Mahan, Grace O. Robinson, Andréia Silva da Rocha, David M. Holtzman · 2017 · Annals of Clinical and Translational Neurology
  90. Roles of Microglial and Monocyte Chemokines and Their Receptors in Regulating Alzheimer's Disease-Associated Amyloid-β and Tau Pathologies
    Guedes, Joana R., Lao, Taotao, Cardoso, Ana L., El Khoury, Joseph · 2018 · Frontiers in Neurology
  91. Microglial microRNAs mediate sex-specific responses to tau pathology
    Kodama, Lay, Guzman, Elmer, Etchegaray, Jon I., Li, Yaqiao, Sayed, Faten A., Zhou, Lu, Zhou, Yungui, Zhan, Lihong, Le, David, Udeochu, Joe C. et al. · 2020 · Nature Neuroscience
  92. TREM2-independent microgliosis promotes tau-mediated neurodegeneration in the presence of ApoE4.
    Gratuze, Maud, Schlachetzki, Johannes C.M., D’Oliveira Albanus, Ricardo, Jain, Nimansha, Novotny, Brenna, Brase, Logan, Rodriguez, Lea, Mansel, Clayton, Kipnis, Michal, O’Brien, Sydney et al. · 2023 · Neuron
  93. Neurofibrillary tangle‐like tau pathology induced by synthetic tau fibrils in primary neurons over‐expressing mutant tau
    Jing Guo, Virginia M.‐Y. Lee · 2013 · FEBS Letters
  94. The neuritic plaque facilitates pathological conversion of tau in an Alzheimer’s disease mouse model
    Li, Tong, Braunstein, Kerstin E., Zhang, Juhong, Lau, Ashley, Sibener, Leslie, Deeble, Christopher, Wong, Philip C. · 2016 · Nature Communications
  95. Alcohol drinking exacerbates neural and behavioral pathology in the 3xTg-AD mouse model of Alzheimer's disease
    Jessica L. Hoffman, Sara Faccidomo, Michelle Kim, Seth M. Taylor, Abigail E. Agoglia, Ashley M. May, Evan N. Smith, L.C. Wong, Clyde W. Hodge · 2019 · International review of neurobiology
  96. Resveratrol-Selenium Nanoparticles Alleviate Neuroinflammation and Neurotoxicity in a Rat Model of Alzheimer’s Disease by Regulating Sirt1/miRNA-134/GSK3β Expression
    Omayma AR Abo-Zaid, Mohsen W. Sallam, Sawsan M. El-Sonbaty, Samy Aziza, Basma Emad, Esraa S. A. Ahmed · 2022 · Biological Trace Element Research
  97. Abnormal tau induces cognitive impairment through two different mechanisms: synaptic dysfunction and neuronal loss
    Jing Di, Leah S. Cohen, Christopher P. Corbo, Greg R. Phillips, Abdeslem El Idrissi, Alejandra del C. Alonso · 2016 · Scientific Reports
  98. Promoting tau secretion and propagation by hyperactive p300/CBP via autophagy-lysosomal pathway in tauopathy
    Xu Chen, Yaqiao Li, Chao Wang, Yinyan Tang, Sue‐Ann Mok, Richard M. Tsai, Julio C. Rojas, Anna Karydas, Bruce L. Miller, Adam L. Boxer et al. · 2020 · Molecular Neurodegeneration
  99. Hyperphosphorylation-Induced Tau Oligomers
    Khalid Iqbal, Cheng‐Xin Gong, Fei Liu · 2013 · Frontiers in Neurology
  100. Tau binding protein CAPON induces tau aggregation and neurodegeneration
    Hashimoto, Shoko, Matsuba, Yukio, Kamano, Naoko, Mihira, Naomi, Sahara, Naruhiko, Takano, Jiro, Muramatsu, Shin-ichi, Saido, Takaomi C., Saito, Takashi · 2019 · Nature Communications